MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000–2006 - Vol. 18 No. 1 - January 2012 - Emerging Infectious Disease journal - CDC
Volume 18, Number 1—January 2012
Dispatch
MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000–2006
Article Contents
Author affiliations: The University of Chicago, Chicago, Illinois, USA (M.Z. David, D.L. Zychowski, K. Asthi, S. Boyle-Vavra, R.S. Daum); Centers for Disease Control and Prevention, Anchorage, Alaska, USA (K.M. Rudolph, T.W. Hennessy)
Suggested citation for this articleAbstract
To determine whether methicillin-resistant Staphylococcus aureus (MRSA) USA300 commonly caused infections among Alaska Natives, we examined clinical MRSA isolates from the Alaska Native Medical Center, Anchorage, during 2000–2006. Among Anchorage-region residents, USA300 was a minor constituent among MRSA isolates in 2000–2003 (11/68, 16%); by 2006, USA300 was the exclusive genotype identified (10/10).To investigate this possibility, we conducted surveillance at the Alaska Native Medical Center (ANMC). ANMC is the primary hospital for Alaska Natives residing in the Anchorage area and the statewide referral hospital for the Alaska Tribal Health System.
No hay comentarios:
Publicar un comentario